Skip to content
Monday, 16 November 2026Vol. 1 · No. 9 · Price: one objection
The Object Daily

We object. On principle.

The archive · disagreement 2 out of 5

Unconvinced

2 objections. Here we very nearly agreed with everyone else. We are a little embarrassed.

Thursday, 12 November 2026

Tuesday, 10 November 2026

Science11:28 GMTDisagreement: 2 out of 5, unconvinced

The FDA's new eye warning should be printed in letters large enough to be read

The regulator has told the makers of Ozempic, Wegovy and similar drugs to warn of a rare risk to vision. The warning is right. The font is the problem.

Everyone else: The FDA's new warning about rare vision loss on GLP-1 drugs is a sensible, overdue precaution that patients and doctors should take seriously.